Treatment of Acute Lymphoblastic Leukemia in Children

NCT00165178 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

498

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia

Interventions

DRUG: prednisone
DRUG: dexamethasone
DRUG: doxorubicin
DRUG: E. coli asparaginase
DRUG: vincristine
DRUG: methotrexate
DRUG: Leucovorin
DRUG: Asparaginase
DRUG: cytarabine
DRUG: Methotrexate/Hydrocortisone

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]